Summary
With the artificial pancreas used by the authors, insulin was delivered through a venous infusion and the rate of delivery was adjusted according to data provided by a continuous blood glucose monitor. After different trials we selected control algorithms integrating two parameters: instantaneous blood glucose concentration and increasing or decreasing patterns of blood glucose. A constant basal insulin infusion rate was added and improved the control of glycaemic excursions. Different parameters concerning exogenous insulin homoeostasis were determined. The delay to reach an insulin effect was 18±2 min and was shortened by a priming-dose at the beginning of the infusion. The insulin effect remained for 28±2 min after the infusion had been stopped, but differences were noted in the morning (21±2 min), in the afternoon (32+2 min) and during the night (25±3 min). Insulin needs were evaluated during meals. Related to the amount of carbohydrates, the doses fell from 0.53 units/hr/g of carbohydrate for breakfast to 0.15 for dinner. From these data, it appears that the efficiency of exogenous insulin exhibits a circadian rhythm.
Article PDF
Similar content being viewed by others
References
Albisser, A.M., Leibel, B.S., Ewart, T.G., Davidovac, Z., Zingg, W.: The artificial pancreas. Diabetes22, (Suppl. I) 294 (1973)
Albisser, A.M., Leibel, B.S., Ewart, T.G., Davidovac, Z., Botz, C.K., Zingg, W., Schipper, H., Gander, R.: Clinical control of diabetes by the artificial pancreas. Diabetes23, 397–404 (1974)
Albisser, A.M., Leibel, B.S., Ewart, T.G., Davidovac, Z., Botz, C.K., Zingg, W.: An artificial endocrine pancreas. Diabetes23, 389–396 (1974)
Albisser, A.M., Leibel, B.S., Marliss, E.B., Zinman, B., Botz, C.K., Zingg, W., Murray, F.T., Denoga, A.: Physiopathologie du diabète et pancréas endocrine artificiel. Journées de diabétologie de l'Hotel-Dieu, p. 259. Paris: Flammarion Ed. 1976
Clemens, A.H.: The artificial endocrine pancreas. A model system for computerized feedback control instrumentation. Miles Analecta2, 4–8 (1975)
Clemens, A.H., Chang, P.H., Myers, R.W.: Le developpement d'un système automatique d'infusion d'insuline contrôlé par la glycémie, son système de dosage du glucose et ses algorithmes de contrôle. Journées de diabétologie de l'Hotel Dieu, p. 269. Paris: Flammarion Ed. 1976
Deckert, T., Lorup, B.: Regulation of brittle diabetics by a preplanned insulin infusion program. Diabetologia12, 573–579 (1976)
Gibson, T., Stimmler, L., Jarrett, R.J., Rutland, P., Shiu, M.: Diurnal variations in the effects of insulin on blood glucose plasma non esterified fatty acids and growth hormone. Diabetologia11, 83–88 (1975)
Grodsky, G.M., Bennett, L.L., Smith, D.F., Schmid, F.G.: Effect of pulse administration of glucose or glucagon on insulin secretion in vitro. Metabolism16, 222–223 (1967)
Kerner, W., Thum, Ch., Tamas, Jun G.Y., Beischer, W., Clemens, A.H., Pfeiffer, E.F.: Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial betacell. Horm. Metab. Res.8, 256–261 (1976)
Malherbe, C., De Gasparo, M., De Hertogh, R., Hoet, J.J.: Circadian variations of blood sugar and plasma insulin levels in man. Diabetologia5, 397–404 (1969)
Mirouze, J., Cartry, E., Jaffiol, C.: Analyse de la décroissance de la radioactivite plasmatique après injection d'insuline marquée dans le diabète sucré humain. Ass. Med. Lang. Franç.3, 173–186 (1967)
Mirouze, J., Collard, F., Teisseire, J.P.: Analyse comparative en enregistrement continu des effects hyperglycemiants d'ingestions alimentaires prises à 8, 12, 16 et 19 heures dans le diabète insuliné. Acta Diabetol. Lat.9, 972–982 (1972)
Mirouze, J., Selam, J.L., Pham, T.C.: Infusion insulinique par débit asservi à l'enregistrement glycémique continu. Journées de Diabétologie de l'Hotel Dieu, p. 303. Paris: Flammarion Edition 1976)
Mirouze, J., Collard, F., Selam, J.L., Pham, T. C.: Continuous blood glucose monitoring in insulin treated diabetes. Horm. Metab. Res. (in press)
Ørskov, H., Christensen, N.J.: Plasma disappearance rate of injected human insulin in juvenile diabetic, maturity onset diabetic and non diabetic subjects. Diabetes18, 653–659 (1969)
Page, M. McB, Alberti, K.G.M. M., Greenwood, R., Gumaa, K.A., Hockaday, T.D.R., Lowy, C., Nabarro, J.D.N., Pyke, D.A., Sonksen, P.H., Watkins, P.J., West, T.E.T.: Treatment of diabetic coma with continuous low dose infusion of insulin. Br. Med. J.1974 II, 687–690
Pfeiffer, E.F., Thum, Ch, Clemens, A.H.: The artificial be- tacell. A continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm. Metab. Res.6, 339 (1974)
Pfeiffer, E.F., Thum, Ch, Beischer, W., Meissner, C., Tamas, Jr, G.Y., Clemens, A.H.: The artificial pancreas: application to experimental and clinical research. Abstracts of the 11th Annual Meeting of the E.A.S.D.) Diabetologia11, 369 (1975)
Pfeiffer, E.F., Beischer, W., Thum, Ch., Clemens, A.H.: Le pancréas endocrine artificiel en clinique et en recherche. Journées de Diabétologie de l'Hotel-Dieu, p. 279. Paris: Flammarion Ed. 1976
Sönksen, P.H., Srivastava, M.C., Tompkins, C.V., Nabarro, J.D.N.: Growth hormone and cortisol response to insulin infusion in patients with diabetes mellitus. Lancet 1972II, 155–159
Williams, R.F., Gleason, R.E., Soeldner, J.S.: The half-life of endogenous serum immunoreactive insulin in man. Metabolism17, 1025–1029 (1968)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mirouze, J., Selam, J.L., Pham, T.C. et al. Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes. Diabetologia 13, 273–278 (1977). https://doi.org/10.1007/BF01219712
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01219712